Cargando…
Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
BACKGROUND: Lewy body disease is, after Alzheimer's disease, the second most common cause of senile degenerative dementia with progressive cognitive deterioration, fluctuation of cognitive and motoric functions and psychotic symptoms. It is characterized histologically by the occurrence of Lewy...
Autores principales: | Mirzaei, Siroos, Knoll, Peter, Koehn, Horst, Bruecke, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC151666/ https://www.ncbi.nlm.nih.gov/pubmed/12625839 http://dx.doi.org/10.1186/1471-2385-3-1 |
Ejemplares similares
-
Metabolic Pattern of Asymptomatic Hip-Prosthesis by 18F-FDG-Positron-Emission-Tomography
por: Beslic, Nermina, et al.
Publicado: (2015) -
Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
por: Wu, Albert, et al.
Publicado: (2012) -
(18)F-fluoro-2-deoxy-D-glucose positron emission tomography findings of neurolymphomatosis
por: Jung, Yun Hwa, et al.
Publicado: (2014) -
Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
por: Seiler, Stefanie M. F., et al.
Publicado: (2015) -
Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
por: Miele, Evelina, et al.
Publicado: (2008)